DalsnaFinance › IPOs › Eikon Therapeutics › IPO
Eikon Therapeutics, Inc. completed its initial public offering on NASDAQ on February 5, 2026, pricing at $18.00 a share.
| Ticker | EIKN |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 5, 2026 |
| Offering price | $18.00 |
| Shares offered | 21,177,600 |
| Total raised | $381M |
Eikon Therapeutics, Inc. sold 21,177,600 shares at $18.00 each on NASDAQ. Multiplied out, that is $381.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $381 million total recorded for the deal.
Measured by money raised, Eikon Therapeutics, Inc. was the 69th largest of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million, so this one was about 1.9 times the typical size.
Among the 342 listings on NASDAQ alone, it is the 34th largest.
February 2026 saw 41 completed IPOs in the site's data; by amount raised, Eikon Therapeutics, Inc. was the 4th largest of the 41 deals with a recorded size.
Its $18.00 offer price was tied for the 82nd highest (level with 12 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Eikon Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Eikon Therapeutics, Inc.. This page is general information, not investment advice.